PMID: 9179512Apr 14, 1997Paper

Cost-effectiveness of treatment for drug-abusing pregnant women

Drug and Alcohol Dependence
D S SvikisC E Ball

Abstract

Neonatal intensive care unit (NICU) and drug treatment costs were compared in two groups of pregnant drug abusing women: 100 admissions to a multidisciplinary treatment program and active in care at the time of delivery and 46 controls not entering drug treatment. Clinical measures included urine toxicology at delivery, infant birthweight. Apgar scores and need for and duration of NICU services. Cost measures included drug treatment and NICU costs. Treatment patients showed better clinical outcome at delivery, with less drug use and higher infant estimated gestational age, birthweight and Apgar scores. Infants of treatment patients were also less likely to require NICU services and, for those that did, had a shorter stay. When total cost was examined (including drug treatment), mean net savings for treatment subjects was $4644 per mother/infant pair. The study demonstrates the cost-effectiveness of treatment for pregnant drug abusing women, with savings in NICU costs exceeding costs of drug treatment.

References

Aug 1, 1992·Current Problems in Pediatrics·I J Chasnoff
Jan 11, 1992·The American Journal of Drug and Alcohol Abuse·W H Miller, M C Hyatt
Sep 1, 1992·Medical Care·A C GoodmanJ R Hankin
Sep 1, 1990·American Journal of Obstetrics and Gynecology·C MateraH E Fox
Jan 1, 1989·The American Journal of Drug and Alcohol Abuse·E P Nace
Aug 1, 1986·The International Journal of the Addictions·P S Bauman, S A Levine
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Dec 1, 1993·American Journal of Public Health
Mar 1, 1995·Obstetrics and Gynecology·K Fiscella
Jan 1, 1994·The American Journal of Drug and Alcohol Abuse·A F KolarB S Michaelson
Jun 1, 1994·Archives of Family Medicine·B P YawnR A Yawn
Jun 1, 1993·Clinical Obstetrics and Gynecology·J C Glantz, J R Woods
Dec 1, 1995·Drug and Alcohol Dependence·K SilvermanM L Stitzer
Jul 1, 1996·Journal of Substance Abuse Treatment·L M JanssonF Hackerman

❮ Previous
Next ❯

Citations

Dec 17, 2004·The Journal of Behavioral Health Services & Research·Christine E Grella, Lisa Greenwell
Jul 28, 2010·Current Psychiatry Reports·Lynn HullDace S Svikis
Oct 6, 2000·General Hospital Psychiatry·M A Adler Cohen, J M Jacobson
May 22, 2003·Drug and Alcohol Dependence·Michelle Tuten, Hendrée E Jones
May 10, 2003·Drug and Alcohol Dependence·Rolley E JohnsonGabriele Fischer
Aug 23, 2001·Journal of Substance Abuse Treatment·W B KissinN A Haug
May 3, 2001·Journal of Psychoactive Drugs·M DaleyC N Williams
Nov 22, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michael T FrenchRaymond L Stephens
Sep 1, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·A Thomas McLellan
Mar 1, 2008·Journal of Addiction Medicine·Gary D Helmbrecht, Siva Thiagarajah
Sep 4, 2009·Journal of Addiction Medicine·Martha Velez, Lauren M Jansson
Aug 28, 2003·The Milbank Quarterly·Peter D JacobsonC Christine Fair
Sep 1, 2000·Alcoholism, Clinical and Experimental Research·J HankinJ Heussner
Jan 1, 2011·International Journal of Family Medicine·Hendrée E JonesMichelle Tuten
Nov 13, 2007·BMC Public Health·Bjørg HjerkinnElin Olaug Rosvold
Dec 22, 2006·Health Marketing Quarterly·Sameer DeshpandeAlexandre Bureau
Dec 18, 2012·Neuropsychiatry·Verena MetzGabriele Fischer
Jan 23, 2014·Addictive Behaviors·Ariadna ForrayKimberly A Yonkers
Aug 20, 2011·Journal of Perinatology : Official Journal of the California Perinatal Association·C H BackesL Cordero
Sep 1, 2002·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Pat PaluzziPatricia Burkhardt
May 23, 2014·Obstetrics and Gynecology Clinics of North America·Nancy A HaugMary E McCaul
Jul 7, 2009·Journal of Substance Abuse Treatment·Gregory BrighamFrankie Kropp
Oct 5, 2010·Birth Defects Research. Part A, Clinical and Molecular Teratology·Anne E GiffordCynthia F Bearer
Jun 30, 2004·Journal of Substance Abuse Treatment·Wendy B KissinMaxine L Stitzer
Mar 30, 2000·Primary Care·E H Morrison
Mar 23, 2005·Journal of Substance Abuse Treatment·Marisa DominoSukyung Chung
Dec 20, 2014·Journal of Addiction Medicine·Caitlin E MartinMishka Terplan
Jul 7, 2007·Substance Use & Misuse·Lauren M JanssonHendrée E Jones
Jun 23, 2009·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Tatiana N NanovskayaMahmoud S Ahmed
Jul 23, 2009·Scandinavian Journal of Public Health·Bjørg HjerkinnMorten Lindbaek
Nov 24, 2018·Nature Reviews. Disease Primers·Mara G CoyleHendrée E Jones
Mar 18, 2011·The American Journal of Drug and Alcohol Abuse·Hendrée E JonesKevin E O'Grady
May 7, 2003·The American Journal of Drug and Alcohol Abuse·Olivia Silber AshleyThomas M Brady
Oct 10, 2002·Substance Use & Misuse·Hendrée E JonesGiao Tran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Substance Abuse Treatment
Lauren M JanssonF Hackerman
JAMA : the Journal of the American Medical Association
C S PhibbsR M Schwartz
© 2021 Meta ULC. All rights reserved